Literature DB >> 12850481

Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.

Vassiliki Kalotychou1, Katerina Antonatou, Revekka Tzanetea, Evaggelos Terpos, Dimitris Loukopoulos, Yannis Rombos.   

Abstract

Gilbert's syndrome is characterized by mild unconjugated hyperbilirubinemia. The molecular basis of this syndrome usually concerns an additional dinucleotide insertion (TA) in the A(TA)(n)TAA configuration residing in the promoter region of the UGT1 A1 gene. This configuration may vary in length; the "n" represents the different number of TA repeats. The homozygosity A(TA)(7)TAA/A(TA)(7)TAA is involved in Gilbert's syndrome. In many cases of patients with thalassemia intermedia and sickle cell disease considerable variation in bilirubin levels is observed. In this study we investigated the contribution of the A(TA)(7)TAA/A(TA)(7)TAA genotype in the variable unconjugated serum bilirubin levels in 31 Greek patients with thalassemia intermedia and 27 Greek compound heterozygotes for beta thalassemia and sickle cell anemia. Analysis of the A(TA)(n)TAA configuration in the promoter region of the latter patients showed that those who were carrying the homozygosity A(TA)(7)TAA/A(TA)(7)TAA had higher levels of unconjugated bilirubin. These findings suggest that the coexistence of Gilbert's syndrome in patients with thalassemia intermedia and sickle cell disease may be the cause of the elevated values of unconjugated bilirubin, reducing the possibility of excessive hemolysis in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850481     DOI: 10.1016/s1079-9796(03)00118-9

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.

Authors:  Suad AlFadhli; Hassan Al-Jafer; Mays Hadi; Mashael Al-Mutairi; Rasheeba Nizam
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

2.  Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?

Authors:  Laura Alencastro de Azevedo; Joyce Bonazzoni; Sandrine Comparsi Wagner; Mariela Granero Farias; Christina M Bittar; Liane Daudt; Simone Martins de Castro
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

3.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

4.  Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and β(s) Haplotype: First Report on Comparison between Arab-Indian and African β(s) Genes.

Authors:  Said Y Alkindi; Anil Pathare; Shoaib Al Zadjali; Vinodhkumar Panjwani; Fauzia Wasim; Hammad Khan; Pradeep Chopra; Rajagopal Krishnamoorthy; Salam Alkindi
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-11-01       Impact factor: 2.576

5.  Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.

Authors:  Leila Chaouch; Emna Talbi; Imen Moumni; Arij Ben Chaabene; Miniar Kalai; Dorra Chaouachi; Fethi Mallouli; Abderraouf Ghanem; Salem Abbes
Journal:  Dis Markers       Date:  2013-07-28       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.